Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024
Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced the release date for its second-quarter 2024 financial results. The company will disclose the results on Wednesday, August 7, 2024, before the U.S. financial markets open. Following this, Madrigal's management will host a live webcast at 8 a.m. Eastern Time to review the financial and operating results.
Investors and interested parties can access the webcast through the Investor Relations section of Madrigal Pharmaceuticals' website. To ensure a smooth connection, participants are advised to register at least 15 minutes before the scheduled start. The webcast will remain available for approximately two hours after the live event concludes.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha annunciato la data di pubblicazione dei suoi risultati finanziari del secondo trimestre 2024. L'azienda divulgherà i risultati il mercoledì 7 agosto 2024, prima dell'apertura dei mercati finanziari statunitensi. Successivamente, il management di Madrigal ospiterà un webcast dal vivo alle 8 a.m. Eastern Time per rivedere i risultati finanziari e operativi.
Investitori e parti interessate possono accedere al webcast tramite la sezione Relazioni con gli Investitori del sito web di Madrigal Pharmaceuticals. Per garantire una connessione fluida, si consiglia ai partecipanti di registrarsi almeno 15 minuti prima dell'inizio programmato. Il webcast rimarrà disponibile per circa due ore dopo la conclusione dell'evento dal vivo.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha anunciado la fecha de publicación de sus resultados financieros del segundo trimestre de 2024. La compañía revelará los resultados el miércoles 7 de agosto de 2024, antes de la apertura de los mercados financieros en EE. UU. Después de esto, la dirección de Madrigal llevará a cabo un webcast en vivo a las 8 a.m. hora del Este para revisar los resultados financieros y operativos.
Los inversores y partes interesadas pueden acceder al webcast a través de la sección de Relaciones con Inversores del sitio web de Madrigal Pharmaceuticals. Para garantizar una conexión fluida, se aconseja a los participantes registrarse al menos 15 minutos antes del inicio programado. El webcast estará disponible aproximadamente dos horas después de que concluya el evento en vivo.
Madrigal Pharmaceuticals(나스닥: MDGL)는 2024년 2분기 재무 결과 발표 날짜를 발표했습니다. 이 회사는 2024년 8월 7일 수요일에 미국 금융 시장이 개장하기 전 결과를 공개할 예정입니다. 이어서, Madrigal 경영진은 동부 표준시 오전 8시에 재무 및 운영 결과를 검토하기 위한 라이브 웹캐스트를 진행할 것입니다.
투자자 및 이해관계자는 Madrigal Pharmaceuticals 웹사이트의 투자자 관계 섹션을 통해 웹캐스트에 접속할 수 있습니다. 원활한 연결을 위해 참가자는 예정된 시작 시간 최소 15분 전에 등록하는 것이 좋습니다. 라이브 이벤트가 종료된 후 약 2시간 동안 웹캐스트를 이용할 수 있습니다.
Madrigal Pharmaceuticals (Nasdaq: MDGL) a annoncé la date de publication de ses résultats financiers du deuxième trimestre 2024. L'entreprise dévoilera les résultats le mercredi 7 août 2024, avant l'ouverture des marchés financiers américains. Ensuite, la direction de Madrigal animera un webinaire en direct à 8h00, heure de l'Est, pour passer en revue les résultats financiers et opérationnels.
Les investisseurs et les parties intéressées peuvent accéder au webinaire via la section Relations Investisseurs du site web de Madrigal Pharmaceuticals. Pour garantir une connexion fluide, il est conseillé aux participants de s'enregistrer au moins 15 minutes avant l'heure prévue. Le webinaire sera disponible pendant environ deux heures après la fin de l'événement en direct.
Madrigal Pharmaceuticals (Nasdaq: MDGL) hat das Datum für die Veröffentlichung ihrer Finanzergebnisse für das zweite Quartal 2024 bekannt gegeben. Das Unternehmen wird die Ergebnisse am Mittwoch, den 7. August 2024, vor der Eröffnung der US-Finanzmärkte bekannt geben. Im Anschluss daran wird das Management von Madrigal um 8 Uhr Eastern Time eine Live-Webcast veranstalten, um die finanziellen und betrieblichen Ergebnisse zu überprüfen.
Investoren und Interessierte können über den Bereich Investor Relations auf der Webseite von Madrigal Pharmaceuticals auf den Webcast zugreifen. Um eine reibungslose Verbindung zu gewährleisten, wird den Teilnehmern geraten, sich mindestens 15 Minuten vor dem geplanten Beginn zu registrieren. Der Webcast wird etwa zwei Stunden nach Beendigung der Live-Veranstaltung verfügbar sein.
- None.
- None.
CONSHOHOCKEN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its second-quarter 2024 financial results on Wednesday, August 7, 2024, prior to the open of the U.S. financial markets.
Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.
The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.
The webcast will be available approximately two hours after the live webcast.
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, Madrigal Pharmaceuticals, Inc., IR@madrigalpharma.com
Media Contact
Christopher Frates, Madrigal Pharmaceuticals, Inc., media@madrigalpharma.com
FAQ
When will Madrigal Pharmaceuticals (MDGL) release its Q2 2024 financial results?
What time is Madrigal Pharmaceuticals' (MDGL) Q2 2024 earnings webcast scheduled for?
How can investors access Madrigal Pharmaceuticals' (MDGL) Q2 2024 earnings webcast?
How long before the webcast should participants register for Madrigal Pharmaceuticals' (MDGL) Q2 2024 earnings call?
